MedCap AB (publ) (MCAP.ST) Osake Kurssi
MedCap AB (publ) Kurssi
Viimeisten 19 vuoden aikana MedCap AB (publ)n liikevaihto kasvoi 18,1 % vuodessa ja ylsi 2,11 Mrd. SEK:een. Osakekohtainen tulos on kasvanut 53,7 % vuodessa viimeisten 17 vuoden aikana. MedCap AB (publ)n nettomarginaali 10,4 % on pääosin vakaa verrattuna 10,5 %:iin muutama vuosi sitten. MedCap AB (publ)n 12 kuukauden konsensustavoitehinta on 633,93 SEK, noin yli kurssia 14,6 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
MedCap AB (publ) osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
MedCap AB (publ) liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset MedCap AB (publ) -osakkeesta
MedCap AB (publ) operates as a healthcare-focused investment company in Sweden. The company's business model revolves around identifying and investing in innovative healthcare companies with growth potential. MedCap aims to create long-term value by providing financial resources, strategic guidance, and operational support to the companies it invests in. By leveraging its expertise and network within the healthcare industry, MedCap aims to contribute to the development of the healthcare sector and generate profitable returns for its shareholders. MedCap AB (publ) focuses on investments in both listed and unlisted healthcare companies across various therapeutic areas and market segments.
MedCap AB (publ) is primarily active in the healthcare and pharmaceutical industries.
The main competitors of MedCap AB (publ) in the market include other companies operating in the healthcare and pharmaceutical industries. Some prominent competitors are ABC Company, XYZ Pharmaceuticals, and DEF Healthcare. MedCap AB (publ) faces stiff competition in terms of market share, product development, and innovation. However, it has managed to establish a strong presence and competitive edge through its unique product offerings, strategic partnerships, and focus on customer satisfaction.
MedCap AB (publ), a leading healthcare investment company, has a rich history and background. Established in 1999, MedCap focuses on investing in and developing innovative companies within the healthcare sector. With a mission to drive growth and create value, MedCap has become well-known for its expertise and long-term approach. The company has an impressive track record of successful investments and collaborations, contributing to advancements in medical technology, pharmaceuticals, and healthcare services. MedCap AB (publ) continues to foster strategic partnerships and actively seeks opportunities to support promising healthcare ventures, ensuring its continued growth and impact in the industry.
MedCap AB (publ) has achieved several significant milestones in its journey. One of the key milestones for the company was the successful completion of its initial public offering (IPO), which provided a platform for increased visibility and access to capital. Additionally, MedCap AB (publ) has made major strides in expanding its portfolio through strategic acquisitions and partnerships, strengthening its position in the market. The company's commitment to continuous innovation and research has also led to the development of groundbreaking products and therapies, further solidifying its reputation as a leader in the healthcare industry. These achievements underscore MedCap AB (publ)'s dedication to growth and positioning itself as a frontrunner in the market.
MedCap AB (publ) is primarily present in Sweden.
MedCap AB (publ) is a renowned company that holds a strong set of values and corporate philosophy. The company is dedicated to excellence, integrity, and continuous growth. MedCap AB (publ) prioritizes the well-being of its clients and focuses on delivering high-quality services and products. Emphasizing transparency and professionalism, MedCap AB (publ) maintains a customer-centric approach, ensuring utmost trust and satisfaction. With a commitment to innovation and adaptability, MedCap AB (publ) aims to stay ahead in the ever-evolving stock market landscape, offering its clients unmatched opportunities and value. Trust MedCap AB (publ) for a reliable and principled partner in your investment journey.
Analyytikot asettavat tällä hetkellä MedCap AB (publ)-osakkeelle keskimääräisen tavoitehinnan 633,93 SEK (mediaani: 633,93 SEK), mikä merkitsee +14,6 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä MedCap AB (publ)-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat MedCap AB (publ)-yhtiöltä 2,39 Mrd. SEK liikevaihtoa ja 22,94 SEK osakekohtaista tulosta.
Nykyisellä valuuttakurssilla MedCap AB (publ)-osake noteerataan hintaan 50,45 EUR (553,00 SEK).
MedCap AB (publ)-osake (MCAP.ST) on listattuna 4 pörssissä, muun muassa: Frankfurt (61MA.F), München (61MA.MU), Stockholm (MCAP.ST).
The company MedCap AB (publ) is a Swedish company specialized in investments in the healthcare sector. MedCap's business model is based on identifying and financing promising developments and companies in the healthcare sector to support their further growth and expansion of their services. MedCap is divided into various divisions. The Consumer Goods and Devices division is a leader in the Scandinavian region, offering innovative and high-quality products for the healthcare market. Their products include consumables for home care, disposable products for hospitals, and surgical instruments. The company works closely with reputable medical facilities to ensure their products meet customer needs. Another division of MedCap is the Life Science business field. Here, the company participates in research projects relevant to the development of new drugs and therapies. MedCap collaborates closely with emerging biotech companies and start-ups, providing financial support for development projects. The company aims to be a pioneer in the growing and innovative healthcare sector through its investments in Life Science. Another important pillar of MedCap is the healthcare services sector. In this area, the company offers extensive services to healthcare sector companies, including outsourcing of pharmaceutical and laboratory services, consulting for product launches, training for medical professionals, and the provision of digital health solutions. For example, in recent years, the company has strengthened its position as a leader in digital medicine in Scandinavia through the establishment of telemedicine companies. Overall, MedCap focuses on diversification and innovative growth in all parts of the healthcare sector. The company aims to expand its position as a leading player and pioneer in the industry in the future and to add more high-quality and effective products and services to its portfolio. In summary, MedCap's business model is based on innovative products and services in the healthcare sector. Through targeted investments in research and development, as well as collaborations with established partners and promising start-ups, the Swedish company has become a pioneer in the industry in recent years. With its diverse portfolio and a strategic focus on the needs of the healthcare sector, MedCap is on track to continue its growth trajectory in the future.
odotettu liikevaihto MedCap AB (publ) on 2,39 Mrd. SEK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto MedCap AB (publ) on 344,14 M SEK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
MedCap AB (publ):n hinta-voitto-suhde (P/E) on tällä hetkellä 24,11. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan MedCap AB (publ)-osakkeen arvostusta.
MedCap AB (publ):n hinta-myynti-suhde (P/S) on tällä hetkellä 3,47. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii MedCap AB (publ)-osakkeen arvostuskennuslukuna.
MedCap AB (publ):n Eulpool-laatuscore on 8/10.
MedCap AB (publ):n ISIN on SE0009160872. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
MedCap AB (publ):n WKN on A2ASQ7. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
MedCap AB (publ):n ticker on MCAP.ST. Tämä pörssinoteeraus käytetään MedCap AB (publ)-osakkeiden kauppaan pörssissä.
MedCap AB (publ) osake
MedCap AB (publ) vertaisryhmä
MedCap AB (publ) Ticker
MedCap AB (publ) FIGI
Kaikki tunnusluvut ja syvällinen analyysi MedCap AB (publ):sta
Meidän osakeanalyysimme MedCap AB (publ)-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut MedCap AB (publ):n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: